Absolute Risk-Based Treatment Using Adaptive Blood Pressure Thresholds and Targets Is Crucial to Older Multimorbid Patients With High Fall Risk.

Hypertension

From the Division of Advanced Internal Medicine, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Hospital.

Published: June 2018

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.11297DOI Listing

Publication Analysis

Top Keywords

absolute risk-based
4
risk-based treatment
4
treatment adaptive
4
adaptive blood
4
blood pressure
4
pressure thresholds
4
thresholds targets
4
targets crucial
4
crucial older
4
older multimorbid
4

Similar Publications

Whole-grain foods (WGFs) constitute a large part of humans' daily diet, making risk identification of WGFs important for health and safety. However, existing research on WGFs has paid more attention to revealing the effects of a single hazardous substance or various hazardous substances on food safety, neglecting the mutual influence between individual hazardous substances and between hazardous substances and basic information. Therefore, this paper proposes a causal inference of WGFs' risk based on a generative adversarial network (GAN) and Bayesian network (BN) to explore the mutual influence between hazardous substances and basic information.

View Article and Find Full Text PDF

Background: The optimal approach to the diagnosis of atrial fibrillation in primary care is unclear.

Aim: To determine if external loop recorder (ELR) screening improves atrial fibrillation detection in community dwelling adults with a CHA2DS2-VASc score of greater than two.

Design: Randomised cross-over clinical trial.

View Article and Find Full Text PDF

Background: Risk-based analyses are increasingly popular for understanding heterogeneous treatment effects (HTE) in clinical trials. For time-to-event analyses, the assumption that high-risk patients benefit most on the clinically important absolute scale when hazard ratios (HRs) are constant across risk strata might not hold. Absolute treatment effects can be measured as either the risk difference (RD) at a given time point or the difference in restricted mean survival time (ΔRMST) which aligns more closely with utilitarian medical decision-making frameworks.

View Article and Find Full Text PDF

Introduction: United States Multi-Society Task Force colonoscopy surveillance intervals are based solely on adenoma characteristics, without accounting for other risk factors. We investigated whether a risk model including demographic, environmental, and genetic risk factors could individualize surveillance intervals under an "equal management of equal risks" framework.

Methods: Using 14,069 individuals from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial who had a diagnostic colonoscopy following an abnormal flexible sigmoidoscopy, we modeled the risk of colorectal cancer, considering the diagnostic colonoscopy finding, baseline risk factors (e.

View Article and Find Full Text PDF

Bioanalytical Method Comparison Strategy for Clinical Anti-drug Antibody Immunoassays.

AAPS J

December 2024

Bioanalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, California, 94080, USA.

Per FDA guidance, method comparability should be established if an anti-drug antibody (ADA) assay is run by two or more independent laboratories during a study. Genentech, Inc. is evaluating an immunogenicity risk-based comparability approach consisting of both technical and clinical aspects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!